The EMT transcription factor Zeb2 controls adult murine hematopoietic differentiation by regulating cytokine signaling.
暂无分享,去创建一个
H. Fröhlich | D. Huylebroeck | C. Mecucci | P. Hulpiau | E. Radaelli | J. Haigh | C. Carrillo García | P. Brossart | S. Goossens | C. Matteucci | R. la Starza | I. Gütgemann | Tong Chen | T. Pieters | V. Janzen | T. Riedt | Jin Li | M. Brandes | Sabrina Szczepanski | Natalie Farla | Nikhil Mallela | Linne Dobrosch | Paco Hulpiau
[1] C. Pecquet,et al. Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis. , 2016, Blood.
[2] N. Komatsu,et al. Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms. , 2016, Blood.
[3] Takaaki Ito,et al. Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer. , 2015, The American journal of pathology.
[4] B. Lambrecht,et al. Br Ief Definitive Repor T , 2022 .
[5] L. Bird,et al. Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infection , 2015, The Journal of experimental medicine.
[6] Ole Winther,et al. BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis , 2015, Nucleic Acids Res..
[7] G. Berx,et al. ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling , 2015, Nature Communications.
[8] Heather L. Mulder,et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. , 2014, The New England journal of medicine.
[9] V. Tarabykin,et al. Ntf3 acts downstream of Sip1 in cortical postmitotic neurons to control progenitor cell fate through feedback signaling , 2014, Development.
[10] Yibin Kang,et al. A new Lnc in metastasis: long noncoding RNA mediates the prometastatic functions of TGF-β. , 2014, Cancer cell.
[11] G. Berx,et al. Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression , 2014, Cell Death and Differentiation.
[12] J. Frangos,et al. Rescue of a primary myelofibrosis model by retinoid-antagonist therapy , 2013, Proceedings of the National Academy of Sciences.
[13] G. Fishell,et al. Directed Migration of Cortical Interneurons Depends on the Cell-Autonomous Action of Sip1 , 2013, Neuron.
[14] Juan Zhang,et al. The Transcription Factor Zeb2 Regulates Signaling in Mast Cells , 2012, The Journal of Immunology.
[15] Elliott H. Sherr,et al. Dual-Mode Modulation of Smad Signaling by Smad-Interacting Protein Sip1 Is Required for Myelination in the Central Nervous System , 2012, Neuron.
[16] G. Berx,et al. The EMT regulator Zeb2/Sip1 is essential for murine embryonic hematopoietic stem/progenitor cell differentiation and mobilization. , 2011, Blood.
[17] C. Speyer,et al. Regulation of the Expression and Activity of the Antiangiogenic Homeobox Gene GAX/MEOX2 by ZEB2 and MicroRNA-221 , 2010, Molecular and Cellular Biology.
[18] Julia Schüler,et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.
[19] Klaus-Armin Nave,et al. Sip1 regulates sequential fate decisions by feedback signaling from postmitotic neurons to progenitors , 2009, Nature Neuroscience.
[20] F. Guillemot,et al. Insm1 (IA-1) is an essential component of the regulatory network that specifies monoaminergic neuronal phenotypes in the vertebrate hindbrain , 2009, Development.
[21] G. Berx,et al. The role of the ZEB family of transcription factors in development and disease , 2009, Cellular and Molecular Life Sciences.
[22] S. Pääbo,et al. Insulinoma-Associated 1 Has a Panneurogenic Role and Promotes the Generation and Expansion of Basal Progenitors in the Developing Mouse Neocortex , 2008, Neuron.
[23] D. Scadden,et al. Nf2/merlin regulates hematopoietic stem cell behavior by altering microenvironmental architecture. , 2008, Cell stem cell.
[24] M. Kondo,et al. IL-7 Specifies B Cell Fate at the Common Lymphoid Progenitor to Pre-ProB Transition Stage by Maintaining Early B Cell Factor Expression1 , 2008, The Journal of Immunology.
[25] M. Korpal,et al. The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2* , 2008, Journal of Biological Chemistry.
[26] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[27] G. Goodall,et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.
[28] Sun-Mi Park,et al. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.
[29] Yoshihiro Yamanishi,et al. KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..
[30] David Bryder,et al. Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. , 2007, Cell stem cell.
[31] D. Gilliland,et al. FoxO transcription factors and stem cell homeostasis: insights from the hematopoietic system. , 2007, Cell stem cell.
[32] Asli Silahtaroglu,et al. miR-200b mediates post-transcriptional repression of ZFHX1B. , 2007, RNA.
[33] Sandra A. Moore,et al. MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia , 2006, PLoS medicine.
[34] R. Levine,et al. Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model. , 2006, Blood.
[35] Tariq Enver,et al. Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. , 2005, Blood.
[36] J. Nesland,et al. Snail, Slug, and Smad‐interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma , 2005, Cancer.
[37] S. Orkin,et al. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells , 2004, Nature.
[38] M. Goumans,et al. TGF-beta signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro. , 2003, Blood.
[39] S. Morrison,et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation , 2003, Nature.
[40] A. Postigo,et al. Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins , 2003, The EMBO journal.
[41] L. Nelles,et al. Mice lacking ZFHX1B, the gene that codes for Smad-interacting protein-1, reveal a role for multiple neural crest cell defects in the etiology of Hirschsprung disease-mental retardation syndrome. , 2003, American journal of human genetics.
[42] A. Migliaccio,et al. Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice). , 2002, Blood.
[43] L. Nelles,et al. Generation of the floxed allele of the SIP1 (Smad‐interacting protein 1) gene for Cre‐mediated conditional knockout in the mouse , 2002, Genesis.
[44] H. Lodish,et al. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. , 2001, Blood.
[45] H. Fleming,et al. Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway. , 2001, Immunity.
[46] L. Nelles,et al. SIP1, a Novel Zinc Finger/Homeodomain Repressor, Interacts with Smad Proteins and Binds to 5′-CACCT Sequences in Candidate Target Genes* , 1999, The Journal of Biological Chemistry.
[47] S. Orkin,et al. A lineage‐selective knockout establishes the critical role of transcription factor GATA‐1 in megakaryocyte growth and platelet development , 1997, The EMBO journal.
[48] M Aguet,et al. Inducible gene targeting in mice , 1995, Science.
[49] S. Burstein,et al. Interleukin 6 is a differentiation factor for human megakaryocytes in vitro , 1990, European Journal of Immunology.
[50] J. D. van der Walt,et al. European consensus on grading bone marrow fibrosis and assessment of cellularity. , 2005, Haematologica.